静脉输液治疗新进展：从基础到临床应用
摘要
关键词
全文:
PDF参考
[1]Kalkman LC, Hänscheid T, Krishna S, Grobusch MP. Fluid therapy for severe malaria. Lancet Infect Dis. 2022;22(6):e160-e170.
[2]Widiarti W, Multazam CECZ, Octaviana DS, Susilo H, Alsagaff MY, Wungu CDK. Appropriateness of Fluid Therapy in Cardiogenic Shock Management: A Systematic Review of Current Evidence. Curr Probl Cardiol. 2024;49(1 Pt C):102123.
[3]Barton A, Fisher E, Rees-Milton M. Elastomeric, fillable infusion pumps: an overview for clinical practice. Br J Nurs. 2023;32(Sup15):3-7.
[4]Mejia-Chew C, Heuring B, Salmons J, et al. IVsight as an Infusion Monitor for Patients Receiving Intravenous Therapy: An Exploratory, Unblinded, Single-Center Trial. Curr Ther Res Clin Exp. 100:100747. Published 2024.
[5]Imran M, Kamran A, Fakih N, et al. Intravenous fluid rate of 250 mL/h versus 125 mL/h in nulliparous women: A systematic review and meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 2024;165(2):621-633.
[6]Florez ID, Sierra J, Pérez-Gaxiola G. Balanced crystalloid solutions versus 0.9% saline for treating acute diarrhoea and severe dehydration in children. Cochrane Database Syst Rev. 5:CD013640. Published 2023 May 17.
[7]李素娟,刘春峰,杨妮.生理盐水和平衡盐溶液用于儿童脓毒性休克液体复苏的比较研究.实用药物与临床.2021,24(10):921-925.
[8]Flamm SL, Wong F, Ahn J, Kamath PS. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. Clin Gastroenterol Hepatol. 2022;20(12):2707-2716.
[9]赵婷.智能输液泵控制性持续静脉滴注营养的护理[J].基层医学论坛.2022,26(24):32-35.
[10]Frith J. New horizons in the diagnosis and management of dehydration. Age Ageing. 2023;52(10).
[11]van Rens M, Hugill K, Francia AL, Abdelwahab AH, Garcia KL. Treatment of a neonatal peripheral intravenous infiltration/extravasation (PIVIE) injury with hyaluronidase: a case report. Br J Nurs. 2022;31(8):S31-S36.
[12]李谷维,骆金铠,张杰,毛文平,郭潇潇,刘雨安.静脉输液质量监测闭环追踪系统的构建及应用[J].中华护理杂志.2023,58(23);2829-2834.
[13]Todd M, Nair PK, Ohayon J, Pettigrew RI, Yazdani SK. Liquid Drug Delivery Approaches for the Treatment of Occlusive Arterial Disease: A Systematic Review. J Endovasc Ther. 2024;31(2):203-213.
[14]Wheeler C, Furniss D, Galal-Edeen GH, Blandford A, Franklin BD. Patients' Perspectives on the Quality and Safety of Intravenous Infusions: A Qualitative Study. J Patient Exp. 2020;7(3):380-385.
[15]Yang Q, Ai L, Yang W. Practical value analysis of nursing risk management in intravenous drug allocation. Am J Transl Res. 2021;13(6):7053-7058.
[16]Candeloro M, Guman NAM, Kraaijpoel N, Di Nisio M. Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients. Semin Thromb Hemost. 2021;47(8):972-981.
[17]Zhao Q, Wu D, Wu RF, Wan ZH, Zhang ZQ, Gao L. Predictive utility of a combination of the modified caprini risk assessment score and D-dimer for the evaluation and management of lower extremity venous thrombosis after lung cancer surgery. J Cardiothorac Surg. 2024;19(1):562.
[18]Van Doren L, Steinheiser M, Boykin K, Taylor KJ, Menendez M, Auerbach M. Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions. Am J Hematol. 2024;99(7):1338-1348.
[19]Takahashi Y, Takahira N, Shibuya M, et al. A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study. J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(1):2309499020905711.
[20]Barroso A, Estevinho F, Hespanhol V, Teixeira E, Ramalho-Carvalho J, Araújo A. Management of infusion-related reactions in cancer therapy: strategies and challenges. ESMO Open. 2024;9(3):102922.
[21]Diaz-Rodriguez PE, Molina-Lopez VH, Gonzalez Burgos BA, Nieves-La Cruz C. A Rare Case of Kounis Syndrome Secondary to Infliximab. Cureus. 2023;15(9):e44704.
[22]Blumenstein I, Shanbhag S, Langguth P, Kalra PA, Zoller H, Lim W. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety. Expert Opin Drug Saf. 2021;20(7):757-769.
[23]Reddy S, Shore B, Abramson L, Herfarth HH, Barnes EL. Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease. J Clin Gastroenterol. 2022;56(9):e318-e322.
[24]Barton A. Extravasation and infiltration: under-recognised complications of intravenous therapy. Br J Nurs. 2024;33(7):S18-S26.
[25]Qin ZQ, Yang SF, Chen Y, et al. Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer. World J Clin Cases. 2022;10(4):1164-1171.
[26]Chirnside JG, Malone CJ, Scott JG, Crozier IG. Managing an Advanced Heart Failure Patient at Home With a Long-Term Continuous Intravenous Furosemide Infusion. JACC Case Rep. 2024;29(19):102611.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。